Is zotarolimus eluting stent a safer stent? Six months strut coverage in off-label indications

被引:0
|
作者
Guagliumi, G. [1 ]
Sirbu, V. [1 ]
Musumeci, G. [1 ]
Trivisonno, A. [1 ]
Matiashvili, A. [1 ]
Lortkipanidze, N. [1 ]
Fiocca, L. [1 ]
Voivodjc, A. [1 ]
Mihalcsik, L. [1 ]
Valsecchi, O. [1 ]
机构
[1] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:342 / 342
页数:1
相关论文
共 50 条
  • [1] Mid-long Term Results Of Zotarolimus Eluting Stent I it Off-label, On -label And Not Approved Indications For Use
    Lee, Dae-Hyun
    Tejedor, Paoula
    Botas, Javier
    Duran, Juan M.
    Sanz, Petra
    Robles, Javier
    Lopez-Bescos, Lorenzo
    Perez-Ojeda, German
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 152I - 152I
  • [2] Safety of drug-eluting stent use for off-label indications
    Brunner-La Rocca, H. P.
    Kaiser, C.
    Leibundgut, G.
    Nietlispach, F.
    Pfisterer, M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 679 - 679
  • [3] Off-Label Use and the Spectre of Drug-Eluting Stent Thrombosis
    Cook, Stephane
    Wenaweser, Peter
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (04) : 273 - 276
  • [4] Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: An optical coherence tomography study
    Davlouros, Periklis A.
    Nikokiris, George
    Karantalis, Vasileios
    Mavronasiou, Eleni
    Xanthopoulou, Ioanna
    Damelou, Anastasia
    Tsigkas, Grigorios
    Alexopoulos, Dimitrios
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 151 (02) : 155 - 159
  • [5] Off-label and On-label Uses of Sirolimus-eluting Stent: Angioscopic Comparison
    Yano, Masamichi
    Awata, Masaki
    Nanto, Shinsuke
    Uematsu, Masaaki
    Morozumi, Takakazu
    Watanabe, Tetsuya
    Onishi, Toshinari
    Iida, Osamu
    Kawamoto, Kenji
    Sera, Fusako
    Minamiguchi, Hitoshi
    Ikeoka, Kuniyasu
    Okamoto, Shin
    Tanaka, Nobuaki
    Yasui, Haruyo
    Ishihara, Takayuki
    Dohi, Tomoharu
    Nagata, Seiki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A42 - A42
  • [6] COST-EFFECTIVENESS OF "OFF-LABEL" DRUG ELUTING STENT VERSUS BARE METAL STENT USE
    Schafer, Pascha
    Sacrinty, Matthew
    Kutcher, Michael A.
    Santos, Renato
    Gandhi, Sanjay K.
    Little, William C.
    Applegate, Robert J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [7] Comparison of neointimal coverage of sirolimus-eluting stent and zotarolimus-eluting stent using optical coherence tomography at 9 months after implantation
    Kim, J. -S.
    Kim, J. -S.
    Ko, Y. -G.
    Choi, D.
    Jang, Y.
    Chung, N.
    Shim, W. -H.
    Cho, S. -Y.
    EUROPEAN HEART JOURNAL, 2008, 29 : 147 - 147
  • [8] Off-Label Use of Drug Eluting Stent with Biodegradable Polymer at 2 Years
    Danzi, Gian Battista
    Wijns, William
    Perisic, Zoran
    Bossa, Francisco
    Koning, Rene
    Kala, Petr
    Fath-Oroubadhi, Farzin
    Carrie, Didier
    Moretti, Luciano
    Oppenlaender, Kai
    Barbato, Emanuele
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B51 - B51
  • [9] Long term follow up of on and off-label drug eluting stent implantation
    Qasim, A.
    Cosgrave, J.
    Latib, A.
    Airoldi, F.
    Colombo, A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 332 - 332
  • [10] Everolimus-eluting stent suppresses chronic inflammatory reaction compared with bare metal stent in off-label patients
    Shibata, Y.
    Yano, H.
    Horinaka, S.
    Ishimitsu, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 871 - 871